NASDAQ:NCTY

The9 Competitors

$13.44

-3.03 (-18.40 %)

(As of 05/13/2021 12:00 AM ET)

Add

Compare

Today's Range

$13.10

▼

$16.51

50-Day Range

$15.26

▼

$41.40

52-Week Range

$2.04

▼

$89.20

Volume1.58 million shs

Average Volume4.20 million shs

Market Capitalization$203.08 million

P/E RatioN/A

Dividend YieldN/A

Beta2

The9 (NASDAQ:NCTY) Vs. GRVY, UXIN, OPRX, NEWT, ADV, and CASS

Should you be buying NCTY stock or one of its competitors? Companies in the industry of "business services, not elsewhere classified" are considered alternatives and competitors to The9, including Gravity (GRVY), Uxin (UXIN), OptimizeRx (OPRX), Newtek Business Services (NEWT), Advantage Solutions (ADV), and Cass Information Systems (CASS).

The9 vs. Gravity Stock

Gravity (NASDAQ:GRVY) and The9 (NASDAQ:NCTY) are both small-cap computer and technology companies, but which is the superior business? We will contrast the two companies based on the strength of their valuation, analyst recommendations, earnings, risk, institutional ownership, profitability and dividends.

Profitability

This table compares Gravity and The9's net margins, return on equity and return on assets.

	Net Margins	Return on Equity	Return on Assets
Gravity	13.14%	35.64%	23.36%
The9	N/A	N/A	N/A

Volatility & Risk

Gravity has a beta of -0.37, suggesting that its stock price is 137% less volatile than the S&P 500. Comparatively, The9 has a beta of 2, suggesting that its stock price is 100% more volatile than the S&P 500.

Institutional & Insider Ownership

7.3% of Gravity shares are owned by institutional investors. 30.8% of The9 shares are owned by insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a company will outperform the market over the long term.

Analyst Ratings

This is a summary of current ratings and recommmendations for Gravity and The9, as reported by MarketBeat.

	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Gravity	0	0	0	0	N/A
The9	0	0	0	0	N/A

Valuation and Earnings

This table compares Gravity and The9's gross revenue, earnings per share (EPS) and valuation.

	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Gravity	$307.18 million	2.48	$31.90 million	N/A	N/A
The9	$50,000.00	4,061.57	$-25,540,000.00	N/A	N/A

Gravity has higher revenue and earnings than The9.

Summary

Gravity beats The9 on 6 of the 9 factors compared between the two stocks.

The9 vs. Uxin Stock

Uxin (NASDAQ:UXIN) and The9 (NASDAQ:NCTY) are both small-cap computer and technology companies, but which is the superior business? We will contrast the two companies based on the strength of their valuation, analyst recommendations, earnings, risk, institutional ownership, profitability and dividends.

Profitability

This table compares Uxin and The9's net margins, return on equity and return on assets.

	Net Margins	Return on Equity	Return on Assets
Uxin	-499.36%	N/A	-105.30%
The9	N/A	N/A	N/A

Volatility & Risk

Uxin has a beta of -0.28, indicating that its share price is 128% less volatile than the S&P 500. Comparatively, The9 has a beta of 2, indicating that its share price is 100% more volatile than the S&P 500.

Analyst Ratings

This is a summary of current ratings and recommmendations for Uxin and The9, as reported by MarketBeat.

	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Uxin	0	0	0	0	N/A
The9	0	0	0	0	N/A

Valuation and Earnings

This table compares Uxin and The9's gross revenue, earnings per share (EPS) and valuation.

	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Uxin	$227.64 million	3.34	$-350,840,000.00	($0.60)	-4.28
The9	$50,000.00	4,061.57	$-25,540,000.00	N/A	N/A

The9 has lower revenue, but higher earnings than Uxin.

Summary

The9 beats Uxin on 5 of the 6 factors compared between the two stocks.

The9 vs. OptimizeRx Stock

OptimizeRx (NASDAQ:OPRX) and The9 (NASDAQ:NCTY) are both small-cap computer and technology companies, but which is the superior business? We will contrast the two companies based on the strength of their valuation, analyst recommendations, earnings, risk, institutional ownership, profitability and dividends.

Profitability

This table compares OptimizeRx and The9's net margins, return on equity and return on assets.

	Net Margins	Return on Equity	Return on Assets
OptimizeRx	-16.20%	-10.86%	-8.66%
The9	N/A	N/A	N/A

Volatility & Risk

OptimizeRx has a beta of 0.82, suggesting that its stock price is 18% less volatile than the S&P 500. Comparatively, The9 has a beta of 2, suggesting that its stock price is 100% more volatile than the S&P 500.

Institutional & Insider Ownership

62.4% of OptimizeRx shares are owned by institutional investors. 8.1% of OptimizeRx shares are owned by insiders. Comparatively, 30.8% of The9 shares are owned by insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a company will outperform the market over the long term.

Analyst Ratings

This is a summary of current ratings and recommmendations for OptimizeRx and The9, as reported by MarketBeat.

	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
OptimizeRx	0	0	4	0	3.00
The9	0	0	0	0	N/A

OptimizeRx presently has a consensus target price of $71.00, suggesting a potential upside of 66.04%. Given OptimizeRx's higher possible upside, equities research analysts clearly believe OptimizeRx is more favorable than The9.

Valuation and Earnings

This table compares OptimizeRx and The9's gross revenue, earnings per share (EPS) and valuation.

	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
OptimizeRx	$24.60 million	30.04	$-3,140,000.00	($0.19)	-225.05
The9	$50,000.00	4,061.57	$-25,540,000.00	N/A	N/A

OptimizeRx has higher revenue and earnings than The9.

Summary

The9 beats OptimizeRx on 6 of the 11 factors compared between the two stocks.

The9 vs. Newtek Business Services Stock

Newtek Business Services (NASDAQ:NEWT) and The9 (NASDAQ:NCTY) are both small-cap finance companies, but which is the superior business? We will contrast the two companies based on the strength of their valuation, analyst recommendations, earnings, risk, institutional ownership, profitability and dividends.

Analyst Ratings

This is a summary of current ratings and recommmendations for Newtek Business Services and The9, as reported by MarketBeat.

	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Newtek Business Services	0	2	1	0	2.33
The9	0	0	0	0	N/A

Newtek Business Services presently has a consensus target price of $22.3333, suggesting a potential downside of 27.68%. Given Newtek Business Services' higher possible upside, equities research analysts clearly believe Newtek Business Services is more favorable than The9.

Valuation and Earnings

This table compares Newtek Business Services and The9's gross revenue, earnings per share (EPS) and valuation.

	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Newtek Business Services	$59.29 million	11.67	$41.13 million	$2.33	13.25
The9	$50,000.00	4,061.57	$-25,540,000.00	N/A	N/A

Newtek Business Services has higher revenue and earnings than The9.

Volatility & Risk

Newtek Business Services has a beta of 1.31, suggesting that its stock price is 31% more volatile than the S&P 500. Comparatively, The9 has a beta of 2, suggesting that its stock price is 100% more volatile than the S&P 500.

Profitability

This table compares Newtek Business Services and The9's net margins, return on equity and return on assets.

	Net Margins	Return on Equity	Return on Assets
Newtek Business Services	32.87%	15.07%	6.24%
The9	N/A	N/A	N/A

Institutional & Insider Ownership

13.7% of Newtek Business Services shares are owned by institutional investors. 6.3% of Newtek Business Services shares are owned by insiders. Comparatively, 30.8% of The9 shares are owned by insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a company will outperform the market over the long term.

Summary

Newtek Business Services beats The9 on 8 of the 11 factors compared between the two stocks.

The9 vs. Advantage Solutions Stock

The9 (NASDAQ:NCTY) and Advantage Solutions (NASDAQ:ADV) are both small-cap computer and technology companies, but which is the superior business? We will compare the two businesses based on the strength of their dividends, analyst recommendations, earnings, risk, valuation, profitability and institutional ownership.

Analyst Recommendations

This is a summary of current recommendations for The9 and Advantage Solutions, as provided by MarketBeat.com.

	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
The9	0	0	0	0	N/A
Advantage Solutions	0	2	2	0	2.50

Advantage Solutions has a consensus price target of $13.1667, suggesting a potential upside of 9.27%. Given Advantage Solutions' higher possible upside, analysts clearly believe Advantage Solutions is more favorable than The9.

Earnings & Valuation

This table compares The9 and Advantage Solutions' revenue, earnings per share (EPS) and valuation.

	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
The9	$50,000.00	4,061.57	$-25,540,000.00	N/A	N/A
Advantage Solutions	N/A	N/A	$2.47 million	N/A	N/A

Advantage Solutions has lower revenue, but higher earnings than The9.

Profitability

This table compares The9 and Advantage Solutions' net margins, return on equity and return on assets.

	Net Margins	Return on Equity	Return on Assets
The9	N/A	N/A	N/A
Advantage Solutions	N/A	N/A	N/A

Institutional and Insider Ownership

95.4% of Advantage Solutions shares are held by institutional investors. 30.8% of The9 shares are held by company insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a stock will outperform the market over the long term.

Summary

Advantage Solutions beats The9 on 4 of the 6 factors compared between the two stocks.

The9 vs. Cass Information Systems Stock

The9 (NASDAQ:NCTY) and Cass Information Systems (NASDAQ:CASS) are both small-cap computer and technology companies, but which is the superior business? We will compare the two businesses based on the strength of their dividends, analyst recommendations, earnings, risk, valuation, profitability and institutional ownership.

Analyst Recommendations

This is a summary of current recommendations for The9 and Cass Information Systems, as provided by MarketBeat.com.

	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
The9	0	0	0	0	N/A
Cass Information Systems	0	0	0	0	N/A

Earnings & Valuation

This table compares The9 and Cass Information Systems' revenue, earnings per share (EPS) and valuation.

	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
The9	$50,000.00	4,061.57	$-25,540,000.00	N/A	N/A
Cass Information Systems	$157.24 million	4.17	$30.40 million	N/A	N/A

Cass Information Systems has higher revenue and earnings than The9.

Risk and Volatility

The9 has a beta of 2, suggesting that its share price is 100% more volatile than the S&P 500. Comparatively, Cass Information Systems has a beta of 0.82, suggesting that its share price is 18% less volatile than the S&P 500.

Profitability

This table compares The9 and Cass Information Systems' net margins, return on equity and return on assets.

	Net Margins	Return on Equity	Return on Assets
The9	N/A	N/A	N/A
Cass Information Systems	17.13%	10.20%	1.37%

Institutional and Insider Ownership

62.8% of Cass Information Systems shares are held by institutional investors. 30.8% of The9 shares are held by company insiders. Comparatively, 2.8% of Cass Information Systems shares are held by company insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a stock will outperform the market over the long term.

Summary

Cass Information Systems beats The9 on 6 of the 9 factors compared between the two stocks.